Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our Best Content in Your Email

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Insiders  |  Valuation

International Stem Cell Corp. ISCO

Sector: Healthcare | Sub-Sector: Biotechnology

"International Stem Cell Corp is a biotechnology company. The Company is engaged in the therapeutic and clinical product development. It operates in the therapeutic, cosmeceutical and biomedical research markets."
View modes: 
0 stars

International Stem Cell Corp. (ISCO) Announces Successful In

International Stem Cell Corp. (ISCO) Announces Successful Intracranial Cell Transplantation in Phase I Clinical Study of ISC-hpNSC    Before the opening bell, International Stem Cell...read more
0 stars

International Stem Cell Corp. (ISCO) Reduces Risk through It

International Stem Cell Corp. (ISCO) Reduces Risk through Its Commercial Operations   Although cash burn for International Stem Cell Corp. (OTCQB: ISCO) currently stands at over $0.5 million...read more
0 stars

International Stem Cell Corporation (ISCO) Insiders Inspire

International Stem Cell Corporation (ISCO) Insiders Inspire Confidence with Share Purchases   Recent Form 4 filings with the U.S. Securities and Exchange Commission indicate that the...read more
0 stars

International Stem Cell Corp. (ISCO) Using Extract from Stem

International Stem Cell Corp. (ISCO) Using Extract from Stem Cells to Produce Cosmetic Skin Care Line   Stem cells have near-limitless abilities. They divide, reproduce, and build on each...read more
0 stars

International Stem Cell Corp. (ISCO) Looking to Transform Pa

International Stem Cell Corp. (ISCO) Looking to Transform Parkinson’s Disease Treatment with ISC-hpNSC™ Clinical Trial    Last month, International Stem Cell Corp. (OTCQB: ISCO...read more
0 stars

International Stem Cell Corp. (ISCO) Avoiding Ethical Issues

International Stem Cell Corp. (ISCO) Avoiding Ethical Issues with Stem Cells Derived From Unfertilized Eggs   Human pluripotent stem cells are a type of cell that is self-replicating. In...read more
0 stars

International Stem Cell Corp. (ISCO) Neural Stem Cell Therap

International Stem Cell Corp. (ISCO) Neural Stem Cell Therapy – Ethical, Effective, and Homegrown   A news story out this week (http://dtn.fm/SW1v5) in the MIT Technology Review recounts the...read more
0 stars

International Stem Cell Corp. (ISCO) Protecting its Technolo

International Stem Cell Corp. (ISCO) Protecting its Technology Worldwide   A patent is essentially a government license that gives certain rights to the patent holder, excluding others from...read more
0 stars

Buy One get One Free with International Stem Cell Corporatio

Buy One get One Free with International Stem Cell Corporation (ISCO)   The recent initiation report on International Stem Cell Corporation (OTCQB: ISCO) by Edison Investment Research looks at...read more
0 stars

International Stem Cell Corp. (ISCO) Advancing Clinical Deve

International Stem Cell Corp. (ISCO) Advancing Clinical Development Program for Parkinson’s Disease   International Stem Cell Corp. (OTCQB: ISCO) is a biotechnology company that works with...read more
0 stars

International Stem Cell Corp. (ISCO) Publishes Results from

International Stem Cell Corp. (ISCO) Publishes Results from Preclinical Study of ISC-hpNSC® for Treatment of Parkinson’s Disease    Before the opening bell, International Stem Cell...read more
0 stars

Edison Issues Initiation on International Stem Cell Corp. (I

Edison Issues Initiation on International Stem Cell Corp. (ISCO), Focus on Parkinson’s Potential   In a May 16, 2016, press release, Edison Investment Research announced initiation of...read more
0 stars

International Stem Cell Corp. (ISCO) Moves toward Commenceme

International Stem Cell Corp. (ISCO) Moves toward Commencement of Phase I Clinical Trial through Partnership with Cryoport    Earlier this week, Cryoport, Inc. (NASDAQ: CYRX), the world...read more
0 stars

International Stem Cell Corp. (ISCO) Teams with Leading Cryo

International Stem Cell Corp. (ISCO) Teams with Leading Cryogenic Logistics Provider for Impending Clinical Trial    Before the opening bell, Cryoport, Inc. (NASDAQ: CYRX), a premier...read more
0 stars

International Stem Cell Corp. (ISCO) Covered in Report by Ed

International Stem Cell Corp. (ISCO) Covered in Report by Edison Investment Research   Earlier this week, Edison Investment Research, a leading independent investment intelligence firm...read more
0 stars

International Stem Cell Corp. (ISCO) Introducing a New Era o

International Stem Cell Corp. (ISCO) Introducing a New Era of Medicine with its First Phase of Clinical Trials    International Stem Cell Corporation (OTCQB: ISCO) is a biotechnology...read more
0 stars

International Stem Cell Corporation (ISCO) Reports Operating

International Stem Cell Corporation (ISCO) Reports Operating Results for First Quarter of 2016   Before the opening bell, International Stem Cell Corporation (OTCQB: ISCO) announced its...read more
0 stars

International Stem Cell Corporation (ISCO) passes another Mi

International Stem Cell Corporation (ISCO) passes another Milestone in its Quest for a Parkinson’s Cure    On March 7, 2016, International Stem Cell Corporation (OTCQB: ISCO) announced...read more
0 stars

International Stem Cell Corporation (ISCO) Pushing Forward w

International Stem Cell Corporation (ISCO) Pushing Forward with Regenerative Therapies    There is scant doubt that International Stem Cell Corporation’s (OTCQB: ISCO) attention and...read more
0 stars

International Stem Cell Corporation (ISCO) Continues Upward

International Stem Cell Corporation (ISCO) Continues Upward Climb with Two Successful Subsidiaries    A pioneer in regenerative medicine, International Stem Cell Corporation (OTCQB: ISCO...read more

Stockhouse Deal Room

Register to meet Living Legends:
Robert Friedland, Lukas Lundin, Rob McEwen, Bob Quartermain, Ross Beaty

REGISTER NOW
Promo code "FTVLS784"

Brent Cook: Where are we Going from Here?

Marin Katusa: Rob McEwen interview caused all Gold stocks to Run

China: The Next Crisis - Kyle Bass

Rick Rule Interview, Part I: His Early Career

Jim Rickards and Egon von Greyerz discuss $10,000 gold